HSPA5 and nasopharyngeal carcinoma: In a study by Li et al., triptolide significantly inhibited the expression of GRP78 protein in radiotherapy-resistant nasopharyngeal carcinoma cells (CNE2-SR) and induced apoptosis and M/G2 phase arrest, suggesting that triptolide may serve as a potential radiosensitizer for NPC treatment (138).